Partner Harvey Kesner Represents ChromaDex on $2M Registered Direct Offering of Common Stock and Warrants


Press Release – New York, NY – November 17, 2015 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the firm has represented ChromaDex Corp. (OTCQX: CDXC) (the “Company”), an innovator of proprietary health, wellness, and nutritional ingredients to create science-based solutions for dietary supplements, food and beverage, skin care, sports nutrition, and pharmaceutical products,  in connection with its $2,000,000 registered direct offering.

The Company sold an aggregate of 200,000 units at a purchase price of $10.00 per unit, with each unit consisting of eight shares of the Company’s common stock and a warrant to purchase four shares of common stock at $1.50 per share.

The Sichenzia Ross Friedman Ference LLP team was led by Partner Harvey Kesner and Associates Avital Even-Shoshan and Wei Wang.

Sichenzia Ross Ference LLP

Sichenzia Ross Ference LLP

Sichenzia Ross Ference LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals. We also represent clients in a range of residential and commercial real estate and trusts and estates matters.

Visit SRF's LinkedIn page
Sichenzia Ross Ference LLP